7 Results for "

LOXO-101

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "LOXO-101" in MCE Product Catalog:

17
17 Cited Publications
Cat. No.: HY-12866
CAS No.: 1223403-58-4
Purity:  99.95%
Synonyms: LOXO-101; ARRY-470
Target:  

Trk Receptor Apoptosis

Research Areas:  

Cancer

Larotrectinib (LOXO-101) is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, with low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C).
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-12866A
CAS No.: 1223405-08-0
Purity:  98.96%
Synonyms: LOXO-101 sulfate; ARRY-470 sulfate
Target:  

Trk Receptor Apoptosis

Research Areas:  

Cancer

Larotrectinib sulfate (LOXO-101 sulfate; ARRY-470 sulfate) is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, with low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C).
loading...
    loading...
Cat. No.: HY-12866R
CAS No.: 1223403-58-4
Synonyms: LOXO-101 (Standard); ARRY-470 (Standard)
Research Areas:  

Cancer

Larotrectinib (Standard) is the analytical standard of Larotrectinib. This product is intended for research and analytical applications. Larotrectinib (LOXO-101) is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, with low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C).
loading...
    loading...
Cat. No.: HY-12866AR
CAS No.: 1223405-08-0
Synonyms: LOXO-101 sulfate (Standard); ARRY-470 sulfate (Standard)
Research Areas:  

Cancer

Larotrectinib sulfate (Standard) is the analytical standard of Larotrectinib sulfate. This product is intended for research and analytical applications. Larotrectinib sulfate (LOXO-101 sulfate; ARRY-470 sulfate) is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, with low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C).
loading...
    loading...
Cat. No.: HY-12866S1
Synonyms: LOXO-101-d4; ARRY-470-d4
Larotrectinib-d4 (LOXO-101-d4) is the deuterium labeled Larotrectinib (HY-12866). Larotrectinib (LOXO-101) is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, with low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C).
loading...
    loading...
Cat. No.: HY-144451
CAS No.: 2823342-34-1
Target:  

Trk Receptor

Research Areas:  

Cancer

TRK-IN-12 (Compound 9e) is a potent inhibitor of TRK (TRK G595R IC50 = 13.1 nM). TRK-IN-12 is a macrocyclic derivative compound. TRK-IN-12 shows significant antiproliferative activity in the Ba/F3-LMNA-NTRK1 cell line (IC50 = 0.080 μM). TRK-IN-12 has shown a better inhibitory effect (IC50 = 0.646 μM) than control agent LOXO-101 in Ba/F3-LMNA-NTRK1-G595R cell line .
loading...
    loading...
Cat. No.: HY-12866B
CAS No.: 1223404-68-9
Synonyms: (R)-LOXO-101; (R)-ARRY-470
Target:  

Trk Receptor

(R)-Larotrectinib is a potent TRK inhibitor with an IC50 value of 28.5 nM for TrkA. (R)-Larotrectinib can be used for researching cancer, inflammatory and certain infectious diseases
loading...
    loading...